Skip to main content
. Author manuscript; available in PMC: 2016 Feb 12.
Published in final edited form as: Circulation. 2014 Apr 17;129(24):2539–2546. doi: 10.1161/CIRCULATIONAHA.113.007595

Figure 5. Expected distribution of longevity benefit in the English population.

Figure 5

Distribution of longevity benefit with statin therapy resulting from distribution of a) total serum cholesterol b) systolic blood pressure c) smoking in the general population with all other risk factors held constant. 4 d) shows the distribution of longevity benefit for total cardiovascular risk using all 3 variables combined in an aggregate risk score using the SCORE algorithm.21